Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil - Wikidata - wikimedia - TriplyDB

Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil

Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil

http://www.wikidata.org/entity/Q33776603

about

Effectiveness of rotavirus vaccines against rotavirus infection and hospitalization in Latin America: systematic review and meta-analysis Effectiveness of monovalent and pentavalent rotavirus vaccine.Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis.Rapid changes in rotaviral genotypes in Ecuador.Chimaeric virus-like particles derived from consensus genome sequences of human rotavirus strains co-circulating in Africa.Dominance of emerging G9 and G12 genotypes and polymorphism of VP7 and VP4 of rotaviruses from Bhutanese children with severe diarrhea prior to the introduction of vaccine.Incidence of rotavirus and circulating genotypes in Northeast Brazil during 7 years of national rotavirus vaccination.Diversity of rotavirus strain circulated in gwangju, republic of Korea.Vaccine-derived NSP2 segment in rotaviruses from vaccinated children with gastroenteritis in Nicaragua.Detection of Rotavirus Genotypes in Korea 5 Years after the Introduction of Rotavirus Vaccines Molecular characterisation of the NSP4 gene of group A human rotavirus G2P[4] strains circulating in São Paulo, Brazil, from 1994 and 2006 to 2010.New insights into rotavirus vaccines.Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses Emerging OP354-Like P[8] Rotaviruses Have Rapidly Dispersed from Asia to Other Continents.Rotavirus genotypes in Malaysia and universal rotavirus vaccination.Oral rotavirus vaccines: how well will they work where they are needed most?Rotavirus genotype distribution after vaccine introduction, Rio de Janeiro, Brazil.Group A rotavirus genotypes and the ongoing Brazilian experience: a review.Emergence of human G2P[4] rotaviruses containing animal derived gene segments in the post-vaccine era.Comparative analysis of the Rotarix™ vaccine strain and G1P[8] rotaviruses detected before and after vaccine introduction in Belgium.Human rotavirus strains circulating in Venezuela after vaccine introduction: predominance of G2P[4] and reemergence of G1P[8].Burden and typing of rotavirus group A in Latin America and the Caribbean: systematic review and meta-analysis.Rotarix®: vaccine performance 6 years postlicensure.Reduction in morbidity and mortality from childhood diarrhoeal disease after species A rotavirus vaccine introduction in Latin America - a review.Impact of rotavirus vaccines on rotavirus disease.Rotavirus vaccination in Brazil: effectiveness and health impact seven years post-introduction.Zoonotic transmission of rotavirus: surveillance and control.Rotavirus genotypes as etiological agents of diarrhoea in general populations of two geographic regions of Brazil.Effect of monovalent rotavirus vaccine on rotavirus disease burden and circulating rotavirus strains among children in Morocco.Diversity of rotavirus strains circulating in children under 5 years of age admitted to hospital for acute gastroenteritis in Morocco, June 2006 to May 2009.Monitoring the circulation of rotavirus among children after the introduction of the Rotarix™ vaccine in Goiânia, Brazil.Rotavirus infections in Detroit, USA, a region of low vaccine prevalence.A first report on the characterization of rotavirus strains in Sierra Leone.Predominance of rotavirus G2P[4] and emergence of G12P[9] strains in Asunción, Paraguay, 2006-2007.Phylogenetic analysis of rotaviruses with genotypes G1, G2, G9 and G12 in Bangladesh: evidence for a close relationship between rotaviruses from children and adults.Molecular epidemiology of group A rotavirus among children admitted to hospital in Salto, Uruguay, 2011-2012: first detection of the emerging genotype G12.Rotavirus epidemiology 5-6 years after universal rotavirus vaccination: persistent rotavirus activity in older children and elderly.Whole genome analysis of Vietnamese G2P[4] rotavirus strains possessing the NSP2 gene sharing an ancestral sequence with Chinese sheep and goat rotavirus strains.Epidemiology of group A rotavirus infection after the introduction of monovalent vaccine in the National Immunization Program of Saudi Arabia.Effectiveness of Pentavalent Rotavirus Vaccine Against a Diverse Range of Circulating Strains in Nicaragua.

P2860

Q26741847-8077F860-08D2-4C05-8A33-03363568A801 Q33819513-EE50D57C-B7CA-4831-BED0-FC1B76CFCEDF Q33883799-68C77D3D-BF81-4580-9B57-8FFC336EB1CF Q33901553-5BCA5279-DE46-40D7-BE72-53FCA0982F0A Q34275545-57F66146-D21F-407D-BDD4-5503587E53CB Q34374508-B357A1CB-83B8-43F5-8E7F-C5B87A59146A Q34434552-94863E85-901E-4573-A9E8-94DBA91F24F5 Q34800411-C926B69B-0AB4-4A4A-B2CE-6B8F84390FB7 Q36025079-F7432349-1F0B-4E46-ADBD-B7DA6203ECFD Q36075467-98F8A50D-7D5C-4BCC-8963-356F47230AC6 Q36341259-752A829F-1485-4DB1-83FC-D13F8F24C015 Q36552854-A2E8DDE9-2736-4FC0-8542-A5713BB9BF68 Q36781547-8F895731-EB17-462E-87F7-7DC01CA9032C Q36801823-91E706A5-6ED5-487F-BF74-2EC26DBCED3E Q36864908-E920DAEE-6D66-49B1-B6E4-25724C8DEF67 Q36903971-330A3E30-88E0-474D-A313-DEA25EDE9CBA Q37139895-71A74B0C-C806-4CF0-ABB7-E845E1D8BBE3 Q37369942-DACC2AF4-F6BB-4B3D-8E4A-FF69F7BD1540 Q37411814-C9EF9482-D9F8-4F91-83DE-1270E418F32B Q37559318-7E977AE6-8F63-488F-8E3C-935A9F29FFA6 Q37713426-96DFAAA7-5DBC-4A2B-BB0E-2F19E20D2C1E Q37850759-47E03B4B-3C48-4F8B-9F4A-0305815267D4 Q37956376-72FEC506-A720-483B-9616-E3CE21F52072 Q37975416-ADB70D0F-CB3D-4F79-9D16-60012B97EAF4 Q38018979-01F2D7BF-42AB-41BC-ADC3-8936DF4D296C Q38168901-F5C9EDB0-06B3-4775-BCC0-E552C3FCE4A5 Q38597203-F8A7F55A-9770-4429-BA83-0FD04E32E9A8 Q38632236-C7CFED3A-FB77-4548-B581-073CB650D493 Q38903517-269C8931-7CD5-43B5-9C11-8D0ABEFC9FD4 Q38903522-091A3796-714E-423A-8261-2907192B2767 Q38915064-1AC78039-4036-4D03-A68C-8BEC6E094C99 Q39639810-9BFBA018-54E2-41D9-85A6-5D4DB68A3E41 Q39790135-847A9F08-D591-4172-ADC4-FA6973AB4689 Q39893820-2931B230-E401-45C2-B9E0-20886868E58F Q39931932-737270D5-595E-4DEC-838C-B2286C5D8EF2 Q40254797-FEDFAF2B-E768-4E9B-8B59-98A4CF45B589 Q40379989-B4FC27DB-A3E5-4E3C-913C-7A73E8DCD9C6 Q40527101-A3AE731C-AC06-4F71-88AE-309BC36B54C9 Q40573143-268F3443-A7B0-4076-B42A-FC1F1285A9E9 Q40722649-04B28C8E-7056-4AA0-A0D7-1F637A8D8D84

P2860

Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil

http://www.wikidata.org/entity/Q33776603

description

2007 nî lūn-bûn

@nan

2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil

@ast

Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil

@en

type

label

Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil

@ast

Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil

@en

prefLabel

Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil

@ast

Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil

@en

P1433

Q33776603-6F86A624-3EE5-4627-AC4B-AAD31561B126

P1476

Q33776603-37515631-68F3-48DB-945B-F73CE8F93CEF

P2093

Q33776603-384DF48C-D534-48B8-9253-B48334E80844

Q33776603-3EB64BA3-8EBE-4B36-BD5B-3C176175CDCE

Q33776603-50AE9108-D022-448B-BA78-97DC09705F5B

Q33776603-67A3192A-1724-4F62-BF95-108B1B4DEA79

Q33776603-6C3B7C26-B459-4E59-8863-F64F883E2800

Q33776603-8659AC10-B704-47C6-B83D-FC82635C222B

Q33776603-8B5A35FD-A50E-452F-8FA8-9D155A965125

Q33776603-A760AC55-07A2-45B9-AAE4-EBCC6F7362CF

Q33776603-BF33C2A0-BEB6-407F-BECE-57B194D4ACCB

Q33776603-CD07D70B-AE90-4BFA-9576-0EAFE205ABC1

P2860

Q33776603-102E2141-2A84-4327-8A38-7F7A6207EF80

Q33776603-1A7D239B-7835-413B-B844-57472BCC70E7

Q33776603-7B130BD6-6FE7-416B-A4D2-D4AA7D58C842

Q33776603-91C97F6F-13DC-4BC4-86BC-11B4F9C4D07C

Q33776603-AE8DD12D-E213-4883-9EFA-14301DF433E2

Q33776603-B3CFE194-02DA-4599-8CDD-7AC00D2352D2

Q33776603-D820437F-AB3B-47BF-AC32-0107D4A14F7F

Q33776603-E9F70BB2-FC35-4E9A-9F26-7CF21185087A

P304

Q33776603-350DE262-4BD7-4054-AF00-FAD9D07E20DE

P31

Q33776603-48C51DBF-0027-4F10-8BB2-6293489CF843

P356

Q33776603-31B3F42A-797A-44FD-BCFC-D343FE9F707D

P433

Q33776603-12998A9E-BF0B-4C37-AEEE-92B5D8709D95

P478

Q33776603-F3137986-0108-4F64-A234-7E0456DAFD1B

P50

Q33776603-4776AC70-EB97-4558-AB20-325E2BBA19BE

P577

Q33776603-F41BBB54-0800-4F47-8396-68292C8C672A

P5875

Q33776603-979B6C17-5C6D-4C2F-8D32-2C29D7250CAF

P698

Q33776603-B8DE783E-E51D-4224-A429-BE26F9249DB4

P921

Q33776603-DFF917A0-7604-4C79-BA55-A964D4A3D3C6

P932

Q33776603-641CD27F-78CF-4B62-B2FB-424BABCB658E

P356

P1433

Emerging Infectious Diseases

P1476

Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil

@en

P2093

Charles A Hart

http://www.w3.org/2001/XMLSchema#string

Eduardo F Salustino

http://www.w3.org/2001/XMLSchema#string

Nigel Cunliffe

http://www.w3.org/2001/XMLSchema#string

Osamu Nakagomi

http://www.w3.org/2001/XMLSchema#string

Paula B Fontes

http://www.w3.org/2001/XMLSchema#string

Ricardo Q Gurgel

http://www.w3.org/2001/XMLSchema#string

Sarah C F Vieira

http://www.w3.org/2001/XMLSchema#string

Toyoko Nakagomi

http://www.w3.org/2001/XMLSchema#string

Vanessa C F Barros

http://www.w3.org/2001/XMLSchema#string

Winifred Dove

http://www.w3.org/2001/XMLSchema#string

P2860

Global illness and deaths caused by rotavirus disease in children.

Rotavirus vaccines: current prospects and future challenges.

Live attenuated human rotavirus vaccine, Rotarix.

Prevalence of G2P[4] and G12P[6] rotavirus, Bangladesh.

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

Anticipating rotavirus vaccines in Brazil: Detection and molecular characterization of emerging rotavirus serotypes G8 and G9 among children with diarrhoea in Recife, Brazil

Rotavirus vaccines—An update

P304

1571-1573

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID1310.070412

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5594209

http://www.w3.org/2001/XMLSchema#string

P698

18258011

http://www.w3.org/2001/XMLSchema#string

P921

P932

2851506

http://www.w3.org/2001/XMLSchema#string